Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin, type I cuticular Ha5 (KRT35) is a protein-coding gene and member of the keratin gene family. It encodes a type I acidic hair keratin that forms heterodimers with type II keratins to build the structural matrix of hair and nails. Found in epithelial tissues, it provides mechanical strength and resilience to hair fibers, contributing to their protective and structural properties. Mutations in KRT35 have been associated with disorders affecting hair and nail morphogenesis, such as ectodermal dysplasia and pilomatrix carcinoma. As a structural protein, KRT35 is not typically targeted by drugs nor used directly as a therapeutic biomarker, but plays a crucial role in epithelial biology through filament organization and differentiation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin, type I cuticular Ha5 (KRT35).